Landelle Caroline
Thoracic oncology, encompassing lung cancer and other malignancies of the thoracic region, is a significant global health concern. Despite advancements in early detection and treatment options, thoracic cancers remain a leading cause of cancer-related mortality. However, the advent of precision medicine has revolutionized the field, offering new hope for patients through targeted therapies and personalized treatment strategies. In this article, we will explore the impact of precision medicine on thoracic oncology and delve into the latest developments in targeted therapies and individualized treatment approaches. This includes primarily lung cancer, but also other malignancies such as thymic tumors, esophageal cancer and malignant pleural mesothelioma.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 